Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0TF2N
|
|||
| Drug Name |
Isoxazole-based bicyclic compound 16
|
|||
| Synonyms |
PMID26924192-Compound-76
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
ORION CORPORATION
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H21ClN2O3
|
|||
| Canonical SMILES |
CC1=C(C(=NO1)C)C2=CC3=C(C=C2OC)N(CCO3)CC4=CC=C(C=C4)Cl
|
|||
| InChI |
1S/C21H21ClN2O3/c1-13-21(14(2)27-23-13)17-10-20-18(11-19(17)25-3)24(8-9-26-20)12-15-4-6-16(22)7-5-15/h4-7,10-11H,8-9,12H2,1-3H3
|
|||
| InChIKey |
QYWOLKVTQWOHRO-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bromodomain and extraterminal domain protein (BET) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Bromodomain and extraterminal domain protein (BET) | Target's Patent Info | [1] | |
| KEGG Pathway | SNARE interactions in vesicular transport | |||
| Reactome | COPII (Coat Protein 2) Mediated Vesicle Transport | |||
| WikiPathways | miR-targeted genes in squamous cell - TarBase | |||
| miR-targeted genes in muscle cell - TarBase | ||||
| miR-targeted genes in lymphocytes - TarBase | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | BET inhibitors in cancer therapeutics: a patent review.Expert Opin Ther Pat. 2016;26(4):505-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.